Request Demo
Last update 19 Apr 2025
BGB-45035
Last update 19 Apr 2025
Overview
Basic Info
Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms BGB-45035 |
Target |
Action modulators |
Mechanism IRAK4 modulators(Interleukin-1 receptor-associated kinase 4 modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with BGB-45035NCT06342713
Phase 1a/1b Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and Its Safety and Tolerability in Patients With Autoimmune Dermatological Diseases
100 Clinical Results associated with BGB-45035
Login to view more data
100 Translational Medicine associated with BGB-45035
Login to view more data
100 Patents (Medical) associated with BGB-45035
Login to view more data
100 Deals associated with BGB-45035
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Phase 1 | China | 03 Jun 2024 | |
| Autoimmune Diseases | Phase 1 | Australia | 03 Jun 2024 | |
| Autoimmune Diseases | Phase 1 | New Zealand | 03 Jun 2024 | |
| Dermatitis, Atopic | Phase 1 | China | 03 Jun 2024 | |
| Dermatitis, Atopic | Phase 1 | Australia | 03 Jun 2024 | |
| Dermatitis, Atopic | Phase 1 | New Zealand | 03 Jun 2024 | |
| prurigo nodularis | Phase 1 | China | 03 Jun 2024 | |
| prurigo nodularis | Phase 1 | Australia | 03 Jun 2024 | |
| prurigo nodularis | Phase 1 | New Zealand | 03 Jun 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free